Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2573 Target Snapshot

ATP-dependent translocase ABCB1 · SINGLE PROTEIN · Mus musculus

213Compounds
138Assays
23Approved Drugs
184.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P21447. Use UniProt P21447 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P21447 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats ATP-dependent translocase ABCB1 as ChEMBL target CHEMBL2573, mapped to UniProt P21447. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
ATP-dependent translocase ABCB1
SINGLE PROTEIN · Mus musculus
As of 2026-09-14
ChEMBL target ID
CHEMBL2573
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P21447
ATP-dependent translocase ABCB1
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether ATP-dependent translocase ABCB1 is the right protein anchor across sources, using UniProt P21447 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelATP-dependent translocase ABCB1
UniProt AccessionP21447
Component TypeProtein
Sequence Length1276 aa

ATP-dependent translocase ABCB1

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as ATP-dependent translocase ABCB1, mapped to UniProt P21447. Sequence length is 1276 aa.

Mapped IDP21447
Review nameATP-dependent translocase ABCB1
OrganismMus musculus
Clinical Profile

Clinical Phase Distribution

23
Approved
1
Phase III
1
Phase I
Assay Mix

Activity Type Distribution

IC50148.0
KI18.0
KD18.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL164611 7.24 Kd 57.0 Preclinical
CHEMBL42160 6.92 Kd 120.0 Preclinical
CHEMBL40638 6.75 Kd 180.0 Preclinical
CHEMBL64391 6.7 IC50 200.0 Approved
CHEMBL29743 6.63 IC50 236.0 Preclinical
CHEMBL41122 6.6 Kd 250.0 Preclinical
CHEMBL490121 6.55 IC50 280.0 Preclinical
CHEMBL29631 6.53 IC50 294.0 Preclinical
CHEMBL28168 6.45 IC50 356.0 Preclinical
CHEMBL40860 6.43 Kd 370.0 Preclinical
Distribution

pChEMBL Value Distribution

39
5.0
24
5.5
10
6.0
8
6.5
1
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

ITRACONAZOLE
CHEMBL64391
Approved 1992
Assay Landscape

Assay Landscape

145
Total Assays
61
Tested Compounds
3
Assay Types
Functional — 123 assays, 26 compounds
BAO Format Assays Compounds Avg pChEMBL
organism-based format 72 0
cell-based format 49 26 5.2
tissue-based format 2 0
Binding — 18 assays, 61 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 12 38 5.5
single protein format 6 23 5.5
ADME — 4 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 4 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine